$87.050
-1.428 (-1.64%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
SYRE-Prognose durch Analyse ähnlicher Charts
Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $87.07 (+0.02%). The 1-week path is $88.29 (+1.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Spyre Therapeutics Inc-Aktien kaufen?
Spyre Therapeutics Inc is currently not a good buy. The stock is trading at $90.36, with a 5-day change of -15.15% and an RSI of 16.467, indicating it is oversold. Despite a strong year-to-date change of +195.49% and a one-year change of +443.36%, the recent insider selling and downgrades in analyst price targets suggest caution. The main risk is the significant net losses, with a reported net income of -$69 million for Q1 2026, which raises concerns about sustainability.
SYRE schloss am Wednesday bei $87.05, nachdem der Kurs -1.64% fallen
Spyre Therapeutics Inc (SYRE) last closed at $87.05, losing -1.64%. These facts feed the 1-day and 1-week SYRE price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Spyre Therapeutics Inc (SYRE) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf SYRE am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für SYRE
Historically the probability of a positive September return for SYRE is 52.27%. December offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.